Search

everythinglearnresearchcommunity

for

Search:↓

A higher genetic risk score increases the chance of getting benign prostatic hyperplasia and affects treatment outcomes in Han Chinese men.

Finasteride reduces sperm count and affects male reproductive function, while Epristeride does not.

Three compounds were found to inhibit a prostate disease-related enzyme and reduce prostate size more effectively than the current treatment, suggesting they could be used for treating benign prostatic hyperplasia.

Androgens like testosterone affect hair growth and oil production differently across body parts and individuals.

An 8-year-old boy's early puberty was caused by a rare hormone-secreting brain tumor, which was successfully treated with surgery.

Men with early balding may have a higher risk of prostate issues, and surgery for prostate cancer has a slight survival benefit over radiation.

Finasteride causes abnormal growth in male mice cells at high doses.

Hormones affect prostate health and disease, with certain hormone imbalances linked to prostate cancer and benign prostatic hyperplasia.

Blocking 5α-reductase can harm memory and brain structure, and increase harmful brain changes in male mice used for Alzheimer's disease research.

Large prostate patients more likely to have hair loss.

A subtle androgen receptor abnormality can allow normal male development and sometimes fertility despite partial androgen resistance.

Testosterone therapy improved physical and social health in a male with 49,XXXXY syndrome.

Finasteride might lower the risk of low-grade prostate cancer but not high-grade cancer, while alpha-blockers might reduce high-grade cancer risk.

Cyproterone acetate implants were more effective at reducing facial hair and improving skin in severe hirsutism than oral treatment.

Finasteride does not prevent bladder cancer.

Leydig cell tumors can cause high testosterone in women and are treated by removing the ovaries.

Baseline PSA levels affect general health and sexual satisfaction in men with BPH treated with finasteride or placebo.

The method accurately measures testosterone metabolites with high sensitivity and low environmental impact.

Finasteride reduces prostate cancer risk but may increase high-grade cancer risk.

Heart-specific steroid metabolism is crucial in cardiac hypertrophy.

Dutasteride reduces DHT more effectively than finasteride.

More prostate biopsies increase the chance of finding cancers that may not need treatment.

5α-reductase inhibitors don't stop bladder cancer from developing or getting worse.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Both injectable contraceptives lower testosterone and SHBG levels, with NET-EN having a greater effect than DMPA-IM.

Cyproterone acetate is a safe treatment that causes mild feminizing effects and is more effective with added estrogens.

Finasteride may reduce bleeding after TURP, but more research needed.

Testosterone therapy had limited benefits for a man with depression and suspected low testosterone, highlighting the need for careful diagnosis and treatment planning.